Articles published by Enlivex Therapeutics Ltd
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
February 07, 2024
Via GlobeNewswire
Tickers
ENLV
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
December 20, 2023
Via GlobeNewswire
Tickers
ENLV
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
September 11, 2023
Via GlobeNewswire
Tickers
ENLV
Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023
Via GlobeNewswire
Tickers
ENLV
Via GlobeNewswire
Tickers
ENLV
Via GlobeNewswire
Tickers
ENLV
Via GlobeNewswire
Tickers
ENLV
Enlivex Appoints Andrew Singer to its Board of Directors
April 17, 2023
Via GlobeNewswire
Tickers
ENLV
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
December 05, 2022
Via GlobeNewswire
Tickers
ENLV
Enlivex to Present at the 37th Annual Meeting of the Society For Immunotherapy Of Cancer
November 10, 2022
Via GlobeNewswire
Tickers
ENLV
Enlivex to Present at the 4th Macrophage-Directed Therapies Summit
October 03, 2022
Via GlobeNewswire
Tickers
ENLV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.